These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33634010)

  • 1. MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer.
    Huang J; Liu H; Zhao Y; Luo T; Liu J; Liu J; Pan X; Tang W
    Front Oncol; 2020; 10():550986. PubMed ID: 33634010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma.
    Lv Y; Huang Z; Lin Y; Fang Y; Chen Z; Pan L; Zhang Y; Xu Z
    Oncoimmunology; 2019; 8(10):e1629260. PubMed ID: 31646073
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and validation of a miRNA-related expression signature for tumor mutational burden in colorectal cancer.
    Xu L; Zheng Q
    World J Surg Oncol; 2021 Feb; 19(1):56. PubMed ID: 33610190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-Based Feature Classifier Is Associated with Tumor Mutational Burden in Head and Neck Squamous Cell Carcinoma.
    Xia Y; Wang Q; Huang X; Yin X; Song J; Ke Z; Duan X
    Biomed Res Int; 2020; 2020():1686480. PubMed ID: 33490233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An miRNA signature associated with tumor mutation burden in endometrial cancer.
    Zhou H; Chen L; Qin M; Lei Y; Li T; Li H; Cheng X
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33141168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.
    Fabrizio DA; George TJ; Dunne RF; Frampton G; Sun J; Gowen K; Kennedy M; Greenbowe J; Schrock AB; Hezel AF; Ross JS; Stephens PJ; Ali SM; Miller VA; Fakih M; Klempner SJ
    J Gastrointest Oncol; 2018 Aug; 9(4):610-617. PubMed ID: 30151257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of the Associations of lncRNA Expression Patterns with Tumor Mutation Burden and Prognosis in Colon Cancer.
    Ding C; Shan Z; Li M; Xia Y; Jin Z
    Onco Targets Ther; 2021; 14():2893-2909. PubMed ID: 33958876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma.
    Xue W; Wang Y; Xie Y; Yang C; Gong Z; Guan C; Wei C; Zhu C; Niu Z
    Front Oncol; 2021; 11():634841. PubMed ID: 34262855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
    Zhao DY; Sun XZ; Yao SK
    World J Gastrointest Oncol; 2021 Jan; 13(1):37-57. PubMed ID: 33510848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study.
    Antoniotti C; Korn WM; Marmorino F; Rossini D; Lonardi S; Masi G; Randon G; Conca V; Boccaccino A; Tomasello G; Passardi A; Swensen J; Ugolini C; Oberley M; Tamburini E; Casagrande M; Domenyuk V; Fontanini G; Giordano M; Abraham J; Spetzler D; Falcone A; Lenz HJ; Cremolini C
    Eur J Cancer; 2021 Sep; 155():73-84. PubMed ID: 34365081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an interpretable radiomic signature for preoperative estimation of tumor mutational burden in lung adenocarcinoma.
    Zhang Y; Yang Y; Ma Y; Liu Y; Ye Z
    Front Genet; 2024; 15():1367434. PubMed ID: 38660677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.
    Zheng K; Wan H; Zhang J; Shan G; Chai N; Li D; Fang N; Liu L; Zhang J; Du R; Wu Q; Li X; Zhang C
    J Transl Med; 2020 May; 18(1):215. PubMed ID: 32466784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
    Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
    EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method.
    Li Z; Jiang L; Zhao R; Huang J; Yang W; Wen Z; Zhang B; Du G
    Medicine (Baltimore); 2021 May; 100(21):e26068. PubMed ID: 34032736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden.
    Huang H; Cao W; Long Z; Kuang L; Li X; Feng Y; Wu Y; Zhao Y; Chen Y; Sun P; Peng P; Zhang J; Yuan L; Li T; Hu H; Li G; Yang L; Zhang X; Hu F; Sun X; Hu D
    Front Oncol; 2022; 12():1030335. PubMed ID: 36713578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-coding RNA Expression Patterns in Stomach Adenocarcinoma Serve as an Indicator of Tumor Mutation Burden and Are Associated With Tumor-Infiltrating Lymphocytes and Microsatellite Instability.
    Yang D; Yu J; Han B; Sun Y; Mo S; Hu J
    Front Cell Dev Biol; 2021; 9():618313. PubMed ID: 33644056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies.
    Cao J; Chen L; Li H; Chen H; Yao J; Mu S; Liu W; Zhang P; Cheng Y; Liu B; Hu Z; Chen D; Kang H; Hu J; Wang A; Wang W; Yao M; Chrin G; Wang X; Zhao W; Li L; Xu L; Guo W; Jia J; Chen J; Wang K; Li G; Shi W
    Oncologist; 2019 Dec; 24(12):e1294-e1302. PubMed ID: 31409745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
    Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a 7-microRNA prognostic signature and identification of hub target genes in colorectal carcinoma.
    Jiang S; Xie X; Jiang H
    Transl Cancer Res; 2022 Feb; 11(2):367-381. PubMed ID: 35281422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.